Primary Record
globo-H
- In stock
- 550 g
- Purity
- 98.1 %
Compound Identifiers & Properties
- PubChem CID
- 5326971
- SMILES
- C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2O[C@@H]3[C@H]([C@@H](O[C@@H]([C@H]3O)CO)O)NC(=O)C)CO)O)O)O)O)O
- Canonical SMILES
- CC(=O)N[C@@H]1[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](CO)O[C@H]1O
Names & Synonyms
- globo-H
- H type I epitope
- H type I
- Globo H
- AC1NS1ES
- RefChem:555774
- GlyTouCan:G40696TO
- Fuca1-2Galb1-3GlcNAcb
- CHEBI:59296
- Epitope ID:130652
- human blood group H type 1 trisaccharide
- H TYPE I TRISACCHARIDE
- Fucalpha1-2Galbeta1-3GlcNAcbeta
- SCHEMBL29379691
- MGSDFCKWGHNUSM-QVPNGJTFSA-N
- alphaLFuc(1-2)betaDGal(1-3)betaDGlcNAc
- G40696TO
- CID5326971
- DB04679
- alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
- CID 5326971
- J806.547K
- NS00071710
- alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc
- Q27126605
- N0001-002707
- alpha-L-Fuc-(1-->2)-beta-D-Gal-(1-->3)-beta-D-GlcNAc
- alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- Fuc-a-1,2-Gal-b-1,3-GalNAc-b-1,3-Gal-a-1,4-Gal-b-1,4-Glc
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
- N-[(2R,3R,4R,5S,6R)-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- 2-(Acetylamino)-3-O-[2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-galactopyranosyl]-2-deoxy-beta-D-glucopyranose
- 3-O-[2-O-(alpha-L-Fucopyranosyl)-beta-D-galactopyranosyl]-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
- N-[(2R,3R,4R,5S,6R)-4-{[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide